Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.-Reference-Cited by-同舟云学术

Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.

Published:1995-06-06 Issue:12 Volume:92 Page:5540-5544
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Maass G.,Schmidt W.,Berger M.,Schilcher F.,Koszik F.,Schneeberger A.,Stingl G.,Birnstiel M. L.,Schweighoffer T.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized controlled phase III trial of adjuvant chemoimmunotherapy with activated cytotoxic T cells and dendritic cells from regional lymph nodes of patients with lung cancer;Cancer Immunology, Immunotherapy;2018-05-31

2. Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy;Journal of Immunotherapy;2018-02

3. Cancer Immunotherapy by Anti-Gal-Mediated In Situ Conversion of Tumors Into Autologous Vaccines;The Natural Anti-Gal Antibody As Foe Turned Friend In Medicine;2018

4. Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens;BMC Cancer;2015-12

5. Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer;Cancer Immunology, Immunotherapy;2015-05-20